Shares of Solventum jumped Tuesday and led S&P 500 gainers intraday after medical device maker Thermo Fisher Scientific said it would acquire the company’s purification and filtration business for $4.

Trian issued the following statement: “Trian commends Solventum on the announced sale of its Purification & Filtration business and believes this is an important first step in the Company’s ...

M health care spinoff Solventum is selling its purification business to Thermo Fisher Scientific for $4.1 billion in cash to pay down its billions in outstanding debt. Solventum CEO Bryan Hanson said ...

and purification & filtration activities. Despite being well positioned and catering to no less than 100,000 clients across the globe, Solventum has been suffering from flattish sales for quite a ...

CEO Bryan Hanson told investors last week that the restructuring plan would save Solventum $120 million annually.

The Journal reported in October that Solventum, the healthcare company spun off from 3M last year, had retained bankers to explore a sale of its purification and filtration unit.

Solventum’s Purification & Filtration business provides purification and filtration technologies for the production of ...

Solventum operates in the healthcare industry through four main segments: MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The company, which spun off from ...